{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["20(3)"],"submitter":["Adamu H"],"pubmed_abstract":["<h4>Background</h4>COVID-19 still poses a major public health challenge worldwide and vaccination remains one of the major interventions to control the disease. Different types of vaccines approved by the World Health Organization (WHO) are currently in use across the world to protect against the disease. This study assessed the prevalence and pattern of adverse events following immunization (AEFI) after receiving COVID-19 vaccine (the Oxford-AstraZeneca vaccine) among the adult population in Sokoto metropolis, North-west, Nigeria.<h4>Methods</h4>We conducted a cross-sectional study among 230 adults in Sokoto metropolis who received COVID-19 vaccines. Data was collected using a structured questionnaire administered via personal phone calls to respondents who were selected via a systematic "],"journal":["PloS one"],"pagination":["e0277585"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11903040"],"repository":["biostudies-literature"],"pubmed_title":["Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria."],"pmcid":["PMC11903040"],"pubmed_authors":["Bawa IA","Lawal S","Sani AM","Adamu H","Adamu AA"],"additional_accession":[]},"is_claimable":false,"name":"Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria.","description":"<h4>Background</h4>COVID-19 still poses a major public health challenge worldwide and vaccination remains one of the major interventions to control the disease. Different types of vaccines approved by the World Health Organization (WHO) are currently in use across the world to protect against the disease. This study assessed the prevalence and pattern of adverse events following immunization (AEFI) after receiving COVID-19 vaccine (the Oxford-AstraZeneca vaccine) among the adult population in Sokoto metropolis, North-west, Nigeria.<h4>Methods</h4>We conducted a cross-sectional study among 230 adults in Sokoto metropolis who received COVID-19 vaccines. Data was collected using a structured questionnaire administered via personal phone calls to respondents who were selected via a systematic ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2025-04-04T01:28:40.242Z","creation":"2025-04-04T01:28:40.242Z"},"accession":"S-EPMC11903040","cross_references":{"pubmed":["40073304"],"doi":["10.1371/journal.pone.0277585"]}}